Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06262399 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 5 to 7v5
  2. Study Identification, Study Statusv4
  3. Study Identification, Study Status, Oversightv3
  4. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 4 to 5
    • Start date changed from estimate of Apr 2024 to Apr 12, 2024
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a follow-up study of subjects who received NTLA-2002 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.
Trial Details
NCT Number NCT06262399
Lead Sponsor Intellia Therapeutics
Conditions
(from sponsor)		 Hereditary Angioedema
Related terms Angioedemas, Hereditary
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov